• Prestained Protein Marker for SepM Assays

  2026-09-19

  Use this Triple color protein ladder to track broad-range separation, transfer efficiency, and protein-size confidence in SepM mutation workflows. Its EDTA-free formulation also supports Phosbind SDS-PAGE and fluorescent membrane imaging without heating or extra loading-buffer preparation.

• Chloroquine BA1002: Mechanisms and Research Uses

  2026-09-18

  Chloroquine is a 4-aminoquinoline and lysosomotropic compound used in malaria, autophagy, immunity, oncology, and antiviral research. Its cellular activity is experimentally broad, but in-vitro antiviral or anticancer results do not establish clinical efficacy or safe self-treatment.

• CFTRinh-172 in Precision CFTR Functional Assays

  2026-09-17

  CFTRinh-172 provides a rapid, reversible way to separate CFTR channel activity from CFTR trafficking in epithelial models. Its selectivity makes it especially useful for validating SHC-1-driven surface-abundance changes, cystic fibrosis research, and preclinical studies of secretory diarrhea.

• Imipenem Assay Design for Translational Research

  2026-09-17

  Imipenem is a semisynthetic thienamycin antibiotic with a distinctive PBP-targeting profile. This guide shows how to connect antibacterial, pharmacodynamic, immune-cell, and sepsis-model readouts into a more rigorous translational research workflow.

• SARS-CoV-2 N Protein Disrupts GADD34 Immunity

  2026-09-16

  This Molecules study identifies an atypical stress-granule mechanism by which SARS-CoV-2 nucleocapsid protein sequesters GADD34 mRNA in N+/G3BP1+ foci. The resulting loss of GADD34 impairs IRF3 nuclear localization and interferon production, providing a mechanistic explanation for viral suppression of innate immunity.

• CFTRinh-172: From Channel Blockade to Translation

  2026-09-16

  CFTRinh-172 offers a precise way to separate CFTR channel activity from trafficking and upstream signaling. This thought-leadership perspective connects mechanistic epithelial biology with assay design, cystic fibrosis research, and translational models of secretory disease.

• Carrier-Platin and the ROS Storm in Cancer Cells

  2026-09-15

  Liu et al. describe carrier-platin, a platinum-based nanotherapeutic designed to generate a rapid intracellular reactive oxygen species burst rather than relying on conventional DNA damage. The study links this mechanism to unusually fast cancer-cell killing, activity in multidrug-resistant models, and a distinct cell-death phenotype that is neither classical apoptosis nor ferroptosis.

• U-73122 Workflow for PLC Signaling and Invasion

  2026-09-15

  U-73122 enables acute phospholipase C inhibition across calcium-flux, chemotaxis, inflammation, and cancer-invasion workflows. This guide pairs practical dosing and handling recommendations with pathway controls that help distinguish PLC-dependent effects from nonspecific loss of cell function.

• Sodium dicloxacillin monohydrate for MSSA research

  2026-09-14

  Build more informative MSSA experiments by pairing extracellular and intracellular efficacy measurements with controlled pH and concentration windows. This workflow also adapts a selective spectrophotometric strategy for practical formulation checks while clearly separating validated evidence from assay-development recommendations.

• Asymmetric Cu Nanozyme for AMI Immune Homeostasis

  2026-09-14

  This study develops a bromine-doped, asymmetrically coordinated copper single-atom nanozyme that improves reactive oxygen species scavenging through electronic-structure engineering. In an acute myocardial infarction model, the material links redox control with cardiomyocyte protection, macrophage phenotype regulation, regulatory T-cell activity, and reduced fibrotic remodeling.

• Plk1 Control of p31comet in Checkpoint Exit

  2026-09-13

  The reference study identifies Polo-like kinase 1 (Plk1) as a negative regulator of p31comet-mediated mitotic checkpoint complex disassembly. By showing that Plk1 phosphorylates p31comet at S102 and suppresses its cooperation with TRIP13, the work explains how cells may prevent premature checkpoint inactivation during mitosis.

• Click-Compatible BmTyr Proximity Labeling in T Cells

  2026-09-12

  The reference study develops a copper-dependent BmTyr platform that labels proximal proteins with an alkyne-phenol probe, avoiding biotin as the primary proximity-labeling handle. In primary T cells, the approach supports fluorescence imaging, affinity-based proteomics, and antibody-independent validation while revealing chromatin-associated localization of NKAP and confirming TNFα pathway components.

• JNJ-10198409: PDGF Receptor Inhibitor Workflows

  2026-09-12

  JNJ-10198409 enables dose-resolved studies of PDGF-BB receptor signaling, proliferation, migration, and angiogenic phenotypes. This practical workflow connects nanomolar biochemical benchmarking with time-resolved pathway controls and troubleshooting for vascular, oncology, and fibrotic disorder research.

• Annexin V-PE Apoptosis Detection Kit Workflow

  2026-09-11

  Build a rapid apoptosis detection workflow around phosphatidylserine externalization, with practical guidance for flow cytometry and live-cell microscopy. The approach is especially useful for connecting GANT61 response kinetics with pathway-level evidence in ALK-positive lymphoma models.

• Gramine and Ferroptosis in TNBC Research

  2026-09-11

  Gramine, also known as 1-(1H-indol-3-yl)-N,N-dimethylmethanamine, is a research compound linked to ferroptosis in triple-negative breast cancer models. A 2026 study associated its activity with CUL3–MTDH regulation, while product data define its formulation, solubility, purity, and storage requirements.

7976 records 1/532 page Next 12345 下5页 Last page